NorthWest Biotherapeutics Inc (NWBO)

[Arby2000]

The first sentence says '...histology consistent with glioblastoma'. The rest of the document snippet raises the issue of a possible misdiagnosis and as you said, there is no connection to NWBO's DCVAX-L or the trial. Based on the two snippets provided, and one appears to be related to reimbursement for travel expenses, this appears, at most, to be raising a malpractice issue. But, given the first sentence, that may also be doubtful.